Clinical Trials

146 enrolled

Phase 1 Active not recruiting

Colonic Neoplasms, Digestive System Diseases, Colorectal Neoplasms

NCT05722327 2026-03-04

Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer

24 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT07448662 2026-03-04

COLBRAIN

700 enrolled

CNSGastrointestinal

Brain Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01570010 2026-02-27

CRC-NORDIET

503 enrolled

Phase EARLY_PHASE1 Active not recruiting

Colorectal Neoplasms

NCT03164486 2026-02-27

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

27 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04428905 2026-02-24

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Phase 3 Active not recruiting

403 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Colorectal Neoplasms

NCT06356597 2026-02-24

Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial

33 enrolled

Colorectal Neoplasms

NCT00548236 2026-02-23

AACT

120 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT05677113 2026-02-23

PERIOP-06

115 enrolled

Phase 3 Active not recruiting

Colorectal Neoplasms

NCT05171660 2026-02-17

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

446 enrolled

Colorectal Neoplasms

NCT04589468 2026-02-06

Researching the Effect of Exercise on Cancer

BreastGastrointestinalGenitourinary

33 enrolled

Breast Neoplasms, Motor Activity, Prostatic Neoplasms, Colorectal Neoplasms

NCT06023004 2026-02-06

The Diverticulitis Study

250 enrolled

Diverticulitis, Colonic, Colorectal Neoplasms

NCT01815359 2026-02-05

ICARuS

292 enrolled

Appendiceal Neoplasms, Colorectal Neoplasms

NCT04587128 2026-02-05

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

34 enrolled

Colorectal Neoplasms

NCT06268015 2026-02-05

BBOpCo

16 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT03637686 2026-02-04

IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer

3,182 enrolled

Colorectal Neoplasms

NCT04787341 2026-02-02

PARERE

214 enrolled

Colorectal Neoplasms

NCT03615599 2026-01-30

AHS-2

BreastGastrointestinalGenitourinary

96,000 enrolled

Breast Neoplasms, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT02600949 2026-01-29

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

Phase 1 Active not recruiting

117 enrolled

Phase 1/2 Active not recruiting

Colorectal Neoplasms

NCT05672316 2026-01-28

Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy

28 enrolled

Phase 2/3 Active not recruiting

Colorectal Neoplasms

NCT04137107 2026-01-26

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

220 enrolled

Phase 1/2 Active not recruiting

Colorectal Neoplasms

NCT04599140 2026-01-22

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

51 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

42 enrolled

Colitis, Ulcerative, Colorectal Neoplasms

NCT05327452 2026-01-21

Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study

BreastGastrointestinalGenitourinary

135 enrolled

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05056896 2026-01-16

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

Phase EARLY_PHASE1 Active not recruiting

161 enrolled

Colorectal Neoplasms

NCT06129604 2026-01-15

Pilot Window of Opportunity Trial (POET)

GastrointestinalGynecologic

10 enrolled

Colorectal Neoplasms, Endometrial Neoplasms

NCT00335816 2026-01-14

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

248 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT03087071 2026-01-12

Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer

59 enrolled

Colorectal Neoplasms

NCT03599752 2026-01-09

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

40 enrolled

Colorectal Neoplasms

NCT03844620 2026-01-09

Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer

100 enrolled